Approvals/TGA/TRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion

Approved

STANDARD

TRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion

Celltrion Healthcare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a7a1a2f1b0d54a0b
Product Name: TRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion
Artg Id: 285815
Artg Name: TRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion
Sponsor: Celltrion Healthcare Australia Pty Ltd
Company Detail Path: /organization/celltrion-healthcare-australia-pty-ltd
Artg Date: 2018-04-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/615942517e8471f265ec1c49242158ed.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/790a198050f48c62392eeee2c9fc0fe0.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

a7a1a2f1b0d54a0b

Type

Standard